0

Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model

Your Price:
$2.99

Fabrication of Nanoparticles of Gemcitabine and its Derivatives

Your Price:
$59.00

EGFR Targeted Gemcitabine PLGA Nanoparticles for Pancreatic Cancer

Your Price:
$73.00

Sensitising cervix against cancer: Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study

Your Price:
$61.00

Gemcitabine: Pharmacology, Clinical Uses and Potential Side Effects (Pharmacology-Research, Safety Testing and Regulation)

Your Price:
$93.11

Induction and Modulation of Resistance to Gemcitabine

Your Price:
$40.00

pp32 (ANP32A) Expression Inhibits Pancreatic Cancer Cell Growth and Induces Gemcitabine Resistance by Disrupting HuR Binding to mRNAs

Your Price:
$2.99

Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF- and chemotherapeutic gemcitabine-induced necroptosis

Your Price:
$2.99

Bladder Cancer

Your Price:
$71.06

Role of Natural Bioactive Compounds in the Rise and Fall of Cancers: Volume 2

Your Price:
$17.13

241044361-20

US

AKIAIZ5EI6YNZ55DMV2A